Zhou Chen agreed to acquire 59% stake in Zentrogene Bioscience Laboratory Limited from Sanai Health Industry Group Company Limited (SEHK:1889) for HKD 22 million on April 17, 2024. The consideration consists of HKD 22 million in cash. As part of the consideration, HKD 22 million was paid towards common equity.

Zentrogene Bioscience Laboratory Limited reported financials for the year December 2023 as: - Net Income: HKD 2.7 million.